RGEN
HOLD / NEUTRALNeutralComposite
53.20
Technical
74.90
Fundamental
38.70
Rank
—
Price
149.78
Hurst
0.53
As of
Aug 5, 2026
Daily
Repligen Corporation
HealthcareMedical Instruments & SuppliesRepligen Corporation manufactures bioprocessing equipment and consumables used in the development and production of biopharmaceutical drugs and diagnostic products. Its product portfolio spans chromatography systems, filtration devices, process monitoring and analytics tools, and various supporting reagents and consumables sold under multiple brand names to pharmaceutical manufacturers, research organizations, and contract manufacturers globally. The company operates across North America, Europe, Asia Pacific, and other international markets.
Market cap
$10.1B
P/E (trailing)
237.59
P/E (forward)
67.24
PEG ratio
1.72
Dividend yield
—
Beta
1.05
52w range
100.99 – 188.73
Return on equity
+1.99%
Profit margin
+5.29%
Revenue growth
+11.90%
Earnings growth
-65.90%
Price history
1Y: 178.19 (+43.3%) · range 102.87–182.03
Cycle position
56/ 100 cycle scoreMID-BULL
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 12 · NOT READY · exit proximity 0
Conviction
28/ 100 · maturity 100%
VScore.4020
Buildup.2054
EMA entry setup.2512
Fundamentals.1539
Volume profile
POC
131.70
Price vs POC
+35.3%
Overhead supply
5%
Runway
open sky
Value area 108.01–150.12 · 5% of 120d volume overhead · clean runway
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| trend-signal | 0.341 | Sep 16, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +9.05% | +14.78% | mature |
| 40d | +4.16% | +14.78% | 26/40d |